Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine and Occlusion Therapy in Amblyopia
NCT07417046Recruiting
- Sponsor
- Minia University
- Start
- Dec 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of fluoxetine in amblyopia (3 arms), sponsored by Minia University. Primary endpoints: Best Corrected Visual Acuity at 6 months, Visual Evoked Potential P-wave amplitude at 6 months and 3 more. Started Dec 2024; status: recruiting.
02
Drugs
fluoxetine
03
Conditions
amblyopia
Beyond the preview
Go deeper on NCT07417046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07417046.